Assistance Publique - Hôpitaux de Paris: Adenocarcinoma trials
The registry lists 12 Adenocarcinoma studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 3No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- 18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic AdenocarcinomaNot yet recruitingNCT05531045
- Evaluation of the Reliability of the Determination of MisMatch Repair Deficiency Status by Endoscopic Biopsies in Oesophagus and Gastric Adenocarcinoma.Not yet recruitingNCT04774367Not applicable
- FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOXRecruitingNCT04167007Phase 3
- Risk of GAstric Adenocarcinoma After Cephalic DuodenopancreatectomyRecruitingNCT03991065Not applicable
- Combination of Capmatinib + Spartalizumab in Advanced Oesogastric AdenocarcinomaSuspendedNCT05135845Phase 2
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized StudyCompletedNCT04065139Phase 2
- Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer SurgeryStatus unknownNCT04005118
- Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.Status unknownNCT03202199Not applicable
- Phenotyping of Small Bowel AdenocarcinomaCompletedNCT02976090
- Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With ChemotherapyTerminatedNCT02404363Phase 3
- Patients Overexposed for a Prostate AdenocarcinomaCompletedNCT00773656
- A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-DocetaxelStatus unknownNCT00764166Phase 3